“…In the canonical TGFb signaling, TGFb1 binds TGFbR1 and TGFbR2 complex, mediating the phosphorylation of SMAD2 and SMAD3 complex, which forms a heterotrimeric complex with SMAD4 and translocates into the nucleus and regulates TGFb1-targeting genes (Derynck and Zhang, 2003). However, our genetic mouse models with deletion of Smad3 (Xu et al, 2012), Smad2, and Smad4 (Huang et al, 2020) showed no effect of SMAD pathway loss on LCs development at steady state but did show an impact on LC repopulation under inflammatory state. Nevertheless, recent studies revealed that both TGFb family members, TGFb1 and BMP7, can potentially signal through BMPR1A or ALK3 to induce LC differentiation in vitro (Borek et al, 2020;Yasmin et al, 2013), and BMP7-ALK3 signaling leads to the differentiation and proliferation of inflammation-associated LCs from bone marrowederived precursors in psoriatic lesions, which promotes the psoriatic epidermal changes in patients with psoriasis as well as in a psoriatic mouse model (Borek et al, 2020).…”